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Disinfection of drinking water is rightly
hailed as one of the major public health tri-
umphs of the 20th century. As a result of
chemical disinfection of water, dramatic
reductions have been observed in both mor-
tality and morbidity from waterborne diseases
(Regli et al. 1993). Recent outbreaks of
waterborne disease, both in the United States
and in South America, serve as vivid
reminders of the necessity of ensuring that
public water supplies are treated properly to
guard against infectious microbial contamina-
tion. Traditionally, drinking water disinfec-
tion has involved the use of chlorine at two
separate points in the treatment process, for
both pretreatment (disinfection at the begin-
ning of the treatment process) and posttreat-
ment (additional disinfection near the end of
the treatment process to maintain a disinfec-
tant residual in the distribution system),
resulting in the production of a wide variety
of disinfection byproducts (DBPs)
(Richardson 1998). The concentrations and
bromo/chloro speciation of the DBPs are
influenced by source water characteristics
such as pH, total organic carbon (TOC) con-
centration, bromide concentration, chlorine
dose, and temperature (Fair 1995; Krasner
2001; Singer 1995). 
Because of concern over the potential
human health effects of the trihalomethanes
(THMs) and the other DBPs formed when
chlorination is used for both pre- and post-
treatment, many treatment plants in the
United States have switched to the use of
only a single postchlorination treatment.
There is also considerable interest in the use
of ozone to disinfect drinking water because
relative to chlorination, ozonation typically
results in decreased concentrations of regu-
lated DBPs such as THMs. An additional
beneﬁt of ozone is that it is a more effective
biocide than chlorine, particularly for
chlorine-resistant microbes such as
Cryptosporidium oocysts. However, when
ozone is used in the United States to disinfect
water in public utility systems, a posttreat-
ment is usually applied to ensure that micro-
bial contamination is controlled during
residence time in the distribution system (i.e.,
the time from treatment at the plant to the
tap in the home). Typical posttreatments
include chlorination and chloramination.
Disinfection strategies that involve ozone can
be characterized as resulting in a decrease in
the total amount of halogenated DBPs
formed; an alteration in the speciation of the
DBPs formed (i.e., increased formation of
brominated species when natural bromide
levels are high); and formation of a few DBPs
of toxicological concern that are not usually
formed by chlorination processes alone. 
Disinfected water contains more than 500
chemical DBPs (Richardson 1998); the rou-
tinely measured/monitored DBPs are listed in
Table 1. However, it should be noted that
many DBPs are still unidentiﬁed; for chlori-
nation, the known DBPs might account for 
< 50% of the mass of total organic halide
(TOX) (Stevens et al. 1989). At the dose lev-
els tested in laboratory experiments, a num-
ber of these DBPs were either carcinogenic or
caused target-organ toxicity, including repro-
ductive/developmental toxicity. These labora-
tory dose levels are high compared with the
low levels, ppb (µg/L) to ppt (ng/L), found in
drinking water. The vast majority of DBPs
have not been investigated toxicologically; in
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Chemical Mixtures
Chemical disinfection of water is a major public health triumph of the 20th century. Dramatic
decreases in both morbidity and mortality of waterborne diseases are a direct result of water disin-
fection. With these important public health beneﬁts comes low-level, chronic exposure to a very
large number of disinfection byproducts (DBPs), chemicals formed through reaction of the chemi-
cal disinfectant with naturally occurring inorganic and organic material in the source water. This
article provides an overview of joint research planning by scientists residing within the various
organizations of the U.S. Environmental Protection Agency Ofﬁce of Research and Development.
The purpose is to address concerns related to potential health effects from exposure to DBPs that
cannot be addressed directly from toxicological studies of individual DBPs or simple DBP mix-
tures. Two factors motivate the need for such an investigation of complex mixtures of DBPs: a) a
signiﬁcant amount of the material that makes up the total organic halide and total organic carbon
portions of the DBPs has not been identiﬁed; and b) epidemiologic data, although not conclusive,
are suggestive of potential developmental, reproductive, or carcinogenic health effects in humans
exposed to DBPs. The plan is being developed and the experiments necessary to determine the
feasibility of its implementation are being conducted by scientists from the National Health and
Environmental Effects Research Laboratory, the National Risk Management Research Laboratory,
the National Exposure Research Laboratory, and the National Center for Environmental
Assessment. Key words: analytical chemistry, complex mixtures, disinfection byproducts, drinking
water, reverse osmosis, toxicology. Environ Health Perspect 110(suppl 6):1013–1024 (2002).
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fact, fewer than 20 individual DBPs
have been subjected to toxicity studies usable
for risk assessment (U.S. EPA 2000a).
Additionally, there are concerns over the toxic
contribution of the unknown fraction. It
should also be noted that little is known
about the potential interactions among the
DBPs, with this being particularly true when
looking beyond the THMs and the haloacetic
acids (HAAs). 
In contrast to what might be extrapo-
lated from laboratory animal studies on indi-
vidual DBPs, some of the epidemiologic
studies conducted to date suggest associa-
tions between human consumption of chlo-
rinated drinking water and adverse health
outcomes, including reproductive and devel-
opmental effects such as increased sponta-
neous abortions and low birth weight (Bove
et al. 1995; Gallagher et al. 1998; Klotz and
Pyrch 1999; Kramer et al. 1992; Waller 
et al. 1998), and bladder and rectal cancer
(Cantor 1997; Cantor et al. 1998, Freedman
et al. 1997; King and Marrett 1996;
McGeehin et al. 1993). In the absence of a
definitive epidemiologic data set, estimation
of the human health risks posed by expo-
sures to DBPs can be developed through
toxicological evaluations of the complex
mixture itself or of the components of the
mixture. Given these options, toxicological
evaluation of the complex mixture rather
than assessment of each individual chemical
separately is preferred because this option
better characterizes the real human exposure.
Importantly, assessment of the complex mix-
ture accounts for any compounded effects
from exposure to the low levels of the multi-
ple DBPs, characterized and unknown,
found in drinking water. 
As most animal DBP toxicity data are
from single-chemical studies and the results
of the human epidemiologic studies are from
exposure to DBP mixtures, there is a need to
conduct scientifically sound and defensible
animal experiments with DBP mixtures. Such
studies should
• focus on those end points identified as of
concern from epidemiologic studies
• provide information that bridges the gap
between single-chemical studies in experi-
mental animals and human exposure to mul-
tiple DBPs by incorporation, where feasible,
of dosimetry in the mixtures experiments
• improve our ability to estimate the risk(s)
from complex mixtures of DBPs at low
exposure levels and multiple routes of
exposure
• provide useful information in areas of con-
cern with regard to DBP mixtures, such as
any change in health risk(s) associated with
moving from chlorination disinfection strate-
gies to alternative disinfection strategies.
The majority of the toxicological research
currently ongoing with DBP mixtures is with
simple, defined mixtures (for a review, see
Simmons et al. 2001). Such work fills an
important data gap, as it provides informa-
tion about the nature of the interactions
(additive, greater than additive, less than
additive) among DBPs known to be toxico-
logically important. Further, it indicates the
appropriateness, or lack thereof, of the
default risk assessment assumptions of dose
additivity for noncancer health effects and
response additivity for cancer. However,
there are simply too many possible combina-
tions of DBPs for it to be feasible to evaluate
more than selected subsets as simple, deﬁned
mixtures. Additionally, and very importantly,
even if it were technically feasible and ﬁnan-
cially possible to examine all possible combi-
nations of all known DBPs, this leaves the
large unknown fraction unevaluated for
potential health effects. 
Working with drinking water concentrates
allows evaluation of the mixture as a whole.
Most previous concentrations have used
methodologies that have resulted in the loss of
the volatile fraction, so the concentrates or
extracts tested consisted of the semivolatiles
and nonvolatiles (Simmons et al. 2001).
Historically, health effects research with con-
centrated drinking water samples, typically
prepared by adsorption on polymer (XAD)
resins, has emphasized detection of muta-
genicity. There has been markedly little toxi-
cological evaluation of complex mixtures of
DBPs in experimental animals. One exception
is a research project, conducted some years
ago, to evaluate concentrates of disinfected
water collected from ﬁve U.S. cities. Despite
evidence of in vitro mutagenicity (Loper et al.
1978), little evidence of carcinogenicity was
exhibited in a mouse skin initiation/promo-
tion assay by reverse osmosis (RO) concen-
trates of disinfected water that had undergone
organic solvent extraction followed by
removal of the organic solvent (Bull et al.
1982). Pregnant CD-1 mice were gavaged
from gestation day 7 (GD7) to GD14 with
concentrates from the same finished water
sources that had been prepared in the same
manner (Kavlock et al. 1979). A volatile
organic mixture, based on the known chemi-
cal levels in drinking water, was restored to
the water concentrates. The authors reported
no adverse effects in the fetus attributable to
either the drinking water concentrates or the
volatile fraction. Based on these results, longer-
term multigenerational dosing and evaluation
of both female and male reproductive toxicity,
as well as developmental toxicity, were 
incorporated into the present research design.
Although epidemiologic and toxicologi-
cal studies suggest that human health effects
from DBP exposure are of concern, these
studies have not demonstrated conclusively
a causal relationship between the typically
low environmental DBP levels to which
humans are exposed and human health
risks. If it is assumed, however, that low-
level DBP exposures cause human health
effects, as suggested in some epidemiologic
studies, several hypotheses can be posed to
explain the discrepancies between the epi-
demiologic results and the expected lack of
effects in epidemiologic studies based on
currently available rodent single-chemical
bioassays, including
• There is an effect from exposure to the
complex mixture of DBPs that is at least
additive (if not synergistic) in nature, so stud-
ies involving low levels of individual DBPs
are inadequate to explain the health effects
found in the positive epidemiologic data.
• Of the more than 500 DBPs identiﬁed, rel-
atively few have undergone evaluation for
reproductive and developmental toxicity in
experimental animals, and the experimental
animal and human data will be reconciled
when sufficient numbers of individual
DBPs have been tested.
• Animal studies differ from human expo-
sures through differences in physiology, bio-
chemistry, anatomy, and lifestyle factors
(e.g., high-fat diets) that prevent animal
studies from demonstrating the same out-
comes observed in humans.
• Typically, laboratory studies expose animals
by only a single route, usually oral, so
effects due to combined oral-dermal-
inhalation exposures, as in the case of
human exposure to DBPs, are not
observed.
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Table 1. Chemical analyses for routinely monitored
DBPs and water parameters.
Bromide
Bromate
Chlorate
Iodide
Iodate
Four THMsa (chloroform, bromodichloromethane, 
dibromochloromethane, bromoform)
Nine HAAsa (monochloroacetic acid, dichloroacetic acid,
trichloroacetic acid, monobromoacetic acid, 
dibromoacetic acid, tribromoacetic acid, 
bromochloroacetic acid, bromodichloroacetic acid,
dibromochloroacetic acid)
Four HANsa (trichloroacetronitrile, dichloroacetonitrile, 
bromochloroacetonitrile, dibromoacetonitrile)
Chloropicrin
Chloral hydrate
Two halopropanonesa (1,1-dichloropropanone, 1,1,1-
trichloropropanone)
Four aldehydes (formaldehyde, acetaldehyde, glyoxal, 
methyl glyoxal)
DOC
TOX
aWithin the chemical classes of THMs, HAAs, HANs, halo-
propanones, and aldehydes, chemical analyses will be
conducted for each individual chemical listed. Using the
THMs as an example, individual analyses will be con-
ducted for chloroform, bromodichloromethane, dibro-
mochloromethane and bromoform.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 1015
• Effects observed in the subset of positive epi-
demiologic studies are the result of confound-
ing factors (exposure to other environmental
pollutants present in the source water or
exposure to industrial pollutants in urban
areas or pesticides in agricultural areas), so
animal studies focused solely on DBPs will
not corroborate epidemiologic ﬁndings.
• The positive epidemiologic ﬁndings are due
to factors other than exposure to environ-
mental chemicals. 
Although the above hypotheses are not
mutually exclusive, this project will test the
first hypothesis, that adverse health effects
exist and are attributable to exposure to the
complex mixture of DBPs. We will evaluate
the effects of the complex mixture of DBPs
through a “mixture as a whole” approach,
and using the chemical analysis of the mix-
ture, attempt to understand whether addi-
tive, greater than additive, or less than
additive interactions are occurring. Further,
to the extent possible, we will examine possi-
ble confounding of the experimental results
by other environmental factors in the drink-
ing water. Results from recent and ongoing
research activities with DBPs (Richardson 
et al. 2002) will provide useful information
on the relative importance of the various
routes of exposure and will provide toxicity
information on previously unevaluated
DBPs. In summary, a critical data gap in
DBP mixtures research is toxicological evalu-
ation in experimental animals of those end
points of concern identiﬁed from epidemiol-
ogy studies. These end points are reproduc-
tive/developmental effects and cancer. These
experiments need to use, to the extent tech-
nically possible and feasible, real-world com-
plex mixtures of DBPs. The overarching
research program goal may be stated as fol-
lows: based on sound, defensible research on
complex mixtures of DBPs, the level of com-
fort associated with ubiquitous human expo-
sure to the byproducts of drinking water
disinfection is either decreased or increased.
Alternatively, this may be stated: estimation
of the potential health risks associated with
exposure to the mixtures of DBPs formed
during disinfection of drinking water will be
improved by the provision of sound, defensi-
ble experimental data on environmentally
relevant mixtures of DBPs.
Research Plan
The research plan described in this article is
designed to evaluate real-world complex
mixtures of DBPs formed by chemical dis-
infection of bromide-containing water. The
proposed research will a) develop health
effects and chemical identity information
for surface water disinfected by chlorina-
tion; b) develop health effects and chemical
identity information for the same surface
water disinfected by an alternative 
disinfection scheme (the alternative disin-
fection scheme used in preliminary experi-
mentation was preozonation followed by
postchlorination as the secondary chemical
treatment); and c) compare the potential
human health risks associated with con-
sumption of water disinfected by different
treatment scenarios.
This initial research plan proposes a
succession of studies that are logical steps
to follow but that may be difficult to
implement because of a number of chal-
lenging technical issues. Although some of
the procedures included in the plan have
been performed often (e.g., water treatment
operations, toxicological assays), aspects of
this research are innovative and novel.
Thus, this research effort has been divided
into three phases; each preceding stage is
expected to influence the structure, practi-
cality, and implementation of the next
stage. The first phase (pretrial run phase)
involved experiments to
• determine whether bromide and iodide
spiking of the source water selected for
the trial run phase was needed and, if
needed, the appropriate levels with which
to spike the source water (see “Addition
of Bromide and Iodide to the Source
Water,” below)
• develop methods for RO membrane con-
centration of water (see “Concentration by
Reverse Osmosis,” below), and
• determine the treatment parameters related
to the palatability of the drinking water
concentrates to rats.
The second phase (trial run phase),
involves experiments to 
• assess the logistics of concentration of large
volumes of water
• compare XAD-resin extraction to RO
membrane concentration
• measure water consumption rates in rodents
to calculate accurately the volumes of con-
centrated water required for the full study
(the third phase)
• perform initial in vivo and in vitro toxico-
logical experiments
• study the chemical stability of the concen-
trated water, and
• perform initial chemical analysis of the
DBPs.
In the third phase (the full study), we use
the information gained and knowledge
learned from the first two phases, as well as
the initial peer review of a concept proposal
for this research, to determine the feasibility
of the proposed experimental plan for the full
study and, assuming feasibility; revise the pro-
posed research plan for the full study; and
conduct the full study to gather extensive tox-
icological data on relevant health end points
and more fully characterize the chemical
composition of the DBPs. 
Figure 1 provides the basic elements of
the full study and their sequence, as outlined
in the concept proposal. They are as follows: 
• Select a surface source water and determine
an appropriate level of bromide and iodide
spiking if needed.
• By splitting the source water into two
streams, disinfect and produce finished
drinking water by two disinfection systems
to allow comparison of both the DBPs and
health consequences of alternative disinfec-
tion scenarios.
• Concentrate these two treated waters by
procedures and methods developed and
evaluated in the pretrial and trial runs and
transport the concentrated waters to other
laboratories.
• Perform extensive chemical analyses both to
qualitatively assess which DBPs/chemicals
are present and to quantitatively measure as
many of these DBPs/chemicals as possible.
Chemical Mixtures • Integrated evaluation of complex mixtures of DBPs
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Figure 1. Flow diagram for the proposed full study. The basic elements of the full study and their sequence
are illustrated.• Perform in vivo toxicological assays and
short-term in vitro experiments with the
concentrated waters, with a targeted focus
on reproductive and developmental end
points, including other important end
points and potential target organs, to the
maximum extent possible.
• Perform statistical analyses and modeling to
test for statistically signiﬁcant effects and to
generate estimates of the proportions of any
observed toxicity that can be attributed to
the known and unknown components of
the mixtures.
• Use these data to estimate the risk posed by
these complex mixtures and the relative dif-
ferences, if any, between the two water
treatments. These steps may be iterative
over time. Aspects of the steps are described
in more detail below. It is expected and
anticipated that elements of the full study
will be modiﬁed to reﬂect both new knowl-
edge gained as a result of the preliminary
experiments leading up to the full study and
new advances in our knowledge of the
potential human health consequences of
exposure to DBPs.
Participants
A multidisciplinary team of investigators
from a wide array of disciplines is needed for
successful completion of this project.
Necessary areas of expertise include water
treatment engineering; DBP source and
occurrence information; analytical chemistry;
target organ toxicology; mixtures toxicology;
statistical analysis and experimental design;
and, risk assessment. In addition to the steer-
ing committee (the authors of this article), a
number of individuals from the research lab-
oratories of the Office of Research and
Development, the National Health and
Environmental Effects Research Laboratory
(NHEERL), the National Risk Management
Research Laboratory (NRMRL), the
National Exposure Research Laboratory
(NERL), and the National Center for
Environmental Assessment (NCEA) partici-
pated in development of the research concept
proposal. These individuals are listed on the
ﬁrst page of this article. 
Water Source
The source water selected for the first and 
second phases is East Fork Lake (EFL, also
known as Harsha Lake). It is a large reservoir
on the Little Miami River at the East Fork
State Park in Ohio. This surface water is rep-
resentative of many in the country with higher
than average TOC, typically 5–8 mg/L. The
Water Industry Data Base of the American
Water Works Association (AWWA) showed
the 50th percentile for surface water TOC to
be 4.0 mg/L (Federal Register 1994). Normal
seasonal changes are expected for the reservoir,
which can alter somewhat the water quality
over the course of a year (TOC, temperature,
water stage, turbidity, etc.). Although uniform
formation conditions (UFCs) (Summers et al.
1996) for chlorine and oocyst inactivation
conditions for ozone are expected to be rela-
tively constant, other conditions may vary
(chlorine and ozone demand [and therefore
doses] may change, coagulation doses vary
with turbidity, bromide spiking may change
as ambient bromide levels change, etc.).
Therefore, temporal changes in ﬁnished water
quality are expected, requiring monitoring
over time to relate consumer equivalents to
animal equivalents.
One source water cannot serve to repre-
sent all typical surface waters. More than one
source water (ideally many more than one)
should be used to gain a comprehensive pic-
ture of the potential health risks resulting
from long-term low-level exposure to the
highly complex, incompletely characterized
mixtures of DBPs formed by chemical disin-
fection of water. It is our hope that the meth-
ods developed for use in the full study will
prove useful, and that they will then be
applied to other water sources to build a rep-
resentative database. 
Keeping in mind that there is no one
ideal water source, EFL does offer several
advantages. Among these are the fact that it
is a reservoir and hence of more consistent
water quality than a free-flowing water
source such as a river. It is the water source
for Clermont County’s Bob McEwen Water
Treatment Plant (5 million gallons per day
(mgd) operational, 10 mgd design). This has
two advantages. It means that the water
being used in the initial stages of this project
is being consumed by a large number of
individuals, adding to the environmental
realism of the effort. Additionally, the his-
torical water-quality database of this water
treatment plant can be used to better under-
stand the degree of variability that might be
expected over time. In addition to these fac-
tors, another consideration was location of a
water source within reasonable trucking dis-
tance of the site of water treatment and con-
centration. The first and second phases of
water treatment and concentration are tak-
ing place at the U.S. EPA facility in
Cincinnati. Ohio. There are two surface
waters with truck access within driving dis-
tance of the facility. One is EFL, the other is
the Ohio River. EFL was selected because,
compared with the Ohio River, it has higher
TOC levels with resultant higher formation
of DBPs, and as a reservoir, it has more con-
sistent water quality and lower day-to-day
variation in turbidity, TOC, bromide, etc.
than the free-flowing Ohio River. Careful
attention must be paid to the criteria used to
select the source water for the full study.
These selection criteria will be provided in
the publication of the full study data.
Addition of Bromide and Iodide 
to the Source Water
Based on the bromide concentration of the
selected surface water(s), the intake water(s)
will be spiked (if necessary) with sufficient
levels of bromide and iodide to ensure repre-
sentative formation of brominated and iodi-
nated species. EFL is a low-bromide water
(typically 10–15 µg/L); when it is used,
higher bromide with a consistent concentra-
tion is obtained by spiking. Bromate, bro-
modichloromethane, dibromoacetic acid, and
other brominated DBPs are of health concern
(Richardson et al. 2002), and their concen-
trations depend in part on the bromide con-
centration of the water being treated.
Chlorination of EFL water that contains
ambient concentrations of bromide typically
results in formation of mainly chlorinated
byproducts such as chloroform, dichloro-
acetic acid and trichloroacetic acid, and
chloral hydrate (Miltner RJ. Personal com-
munication). Bromide spiking is based on
three goals. The ﬁrst goal is to achieve a bro-
mide-spiking level that results in reasonable
formation of the mixed chloro-bromo species
of the THMs but does not result in too much
of a shift from chloroform to bromoform.
Representative concentrations of the four
THMs in surface waters are given in the
Stage 1 D/DBP Rule (Federal Register 1994).
Thus, determination of the amount of bro-
mide required to produce a representative
mixture of the four THMs (chloroform, bro-
modichloromethane, dibromochloromethane,
bromoform), and consequently of HAAs and
haloacetonitriles (HANs), is a goal of the pre-
liminary studies. The second goal is to have
the total THM level close to the 80-µg/L
maximum contaminant level (MCL) in the
1× water (i.e., disinfected water prior to con-
centration) produced by chlorination.
Although the bromide concentration to be
added to the selected surface water(s) is based
on DBP formation under chlorination, the
same bromide and iodide spike is used for the
other disinfection treatments under consider-
ation to allow proper comparison of alterna-
tive disinfection schemes. The third goal is to
have the bromate level of the 1x water close
to the Stage 1 MCL of 10 µg/L. The resulting
bromide concentration will account for both
the ambient and spiked bromide.
The rationale for spiking with iodide is
that bromide and iodide have been found to
co-occur in waters from different locations
that have been tested for the presence of
iodide (Khiari et al. 1999). In addition, there
has been recent concern that iodo-THMs and
other iodinated byproducts could be toxico-
logically important. An effort by the U.S. EPA
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according to probable adverse health effects
resulted in the selection of two of the iodo-
THMs (bromochloroiodomethane and
dichloroiodomethane) in a “top 50” list of
such DBPs. As a result, these iodo-THMs and
others were quantified in waters across the
United States in a recently conducted nation-
wide DBP occurrence study (Gonzalez et al.
2001; Onstad et al. 2001; Weinberg 
et al. 2002). Thus, the rationale for concur-
rent spiking of iodide with bromide is 2-fold:
having iodide present with bromide is approx-
imating a real-world water situation, and hav-
ing iodide present in realistic proportion to
bromide might give rise to toxicologically
important DBPs. The iodide concentration is
typically 10–15% of the bromide concentra-
tion (Khiari et al. 1999); thus, an iodide con-
centration corresponding to 15% of the
bromide spike has been selected for use in this
study. If the selected source water for the full
study contains sufﬁcient bromide and iodide
for representative formation of brominated
and iodinated DBPs, spiking with bromide
and iodide will not be necessary.
Water Disinfection Treatment
Schemes
The choice of treatment was among the
more difﬁcult decisions faced in the planning
process. Although we strongly preferred to
have more than two treatment scenarios,
production and evaluation of more than two
treatment scenarios at one time is not cur-
rently technically feasible. If the project
proves successful, we hope to use the meth-
ods developed here to evaluate other disinfec-
tion schemes. Given the limitation of being
able to carry out only two treatments in this
initial project, chlorination and ozonation/
chlorination were chosen for the preliminary
experiments; chlorine is still the most fre-
quently used disinfectant in the United
States, and ozonation/chlorination is the
most prevalent scenario when ozone is used.
Had an additional treatment been possible at
this stage, chloramination, most likely in
combination with ozonation, would have
been selected, as many treatment plants have
moved to this disinfection scenario. An
ozonated water was included because many
water utilities have moved to ozonation to
meet DBP MCLs and to control Giardia
cysts and Cryptosporidium oocysts. Surveys of
water treatment plants conducted in 1996 by
the American Water Works Association
Research Foundation and in 1998 by
the AWWA Water Quality Division
Disinfection Systems Committee (AWWA
2000) indicate that chlorination/chlorination
(i.e., pretreatment with chlorine/posttreat-
ment with chlorine) is still the most preva-
lent disinfectant scenario and impacts the
largest part of the U.S. population. In addi-
tion, ozonation/chlorination is more preva-
lent than ozonation/chloramination. Our
plans for work beyond that outlined here are
dependent on the successful completion of
the present research. Once the methods are
proven successful, they can be used to exam-
ine both a variety of source waters and a 
variety of disinfection scenarios.
For the chlorination scenario, a
postchlorination scenario was selected for
the preliminary experiments because many
water utilities have moved to this scenario to
meet DBP MCLs (Figure 2). Chlorination
occurs under UFC conditions (a free chlo-
rine concentration of 1 mg/L after 24 hr at
pH 8) (Summers et al. 1996). For the
ozonation/chlorination scenario (Figure 2),
the level of ozone will be set to achieve 1 log
inactivation of Cryptosporidium oocysts,
based on previous inactivation studies
(Owens et al. 2001). Demand studies will be
conducted to determine the ozone dose
required to provide CTs (mean dissolved
ozone concentration in the contactor × the
contactor’s residence time based on tracer
studies) that give 1 log inactivation of
Cryptosporidium oocysts (Owens et al.
2001). An additional advantage to the use of
chlorination as the posttreatment with
ozonation is it allows a comparison to the
postchlorination scenario that minimizes the
number of variables that differ between the
two treatment schemes. Similar to the chlo-
rination-only scenario, the water is chlori-
nated at UFC (Summers et al. 1996). Based
on previous pilot-scale ozonation/chlorina-
tion studies of EFL water without bromide
spiking, under UFCs (Miltner et al. 1996),
the ozonation/chlorination plant is expected
to produce lower concentrations of DBPs
than the chlorination plant, as ozone will
oxidize some chlorine-reactive DBP 
precursor material. 
A conventional ﬁlter was selected because
at the time this project was initiated, the
majority of U.S. water treatment plants that
employed ozonation used conventional ﬁltra-
tion (Rice R. Personal communication).
Additionally, use of conventional filtration
across the two treatment schemes being com-
pared decreases the number of variables that
differ between the two and increases the
opportunity to attribute observed differences
between the two methods of disinfection.
Given the experimental complexity antici-
pated, it will be easier to examine and
attribute risks if only a single aspect of the
treatment changes. It should be noted that the
Stage 1 D/DBP Rule recommends that utili-
ties employing ozonation also employ down-
stream biological ﬁltration to remove some of
the ozone byproducts prior to distribution, as
these DBPs are nutrients for possible bacterial
regrowth in the distribution system.
Concentration by Reverse Osmosis
The concentration of DBPs for evaluation
of mutagenicity is typically done by XAD-
resin techniques. For XAD concentration,
compounds are adsorbed onto the resin of
choice and eluted with an organic solvent
that is then removed by evaporation. The
remaining organics can then be redissolved
in an appropriate solvent for testing. The
hydrophilic and volatile fractions of the
natural organic matter (NOM) and DBPs
are lost in the XAD procedure. The per-
centage of DBPs lost is a function of the
nature of each DBP, the chosen resin, and
the operating conditions. If standard proto-
cols are used, the loss due to break-
through/operating conditions is minimal.
The popularity of XAD-resin concentration
methods has been due, in part, to their
ability to concentrate the organics easily
without inorganic interferences (Wilcox et
al. 1986). However, the amount of water
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Figure 2. Schematic of the water treatment plant and the disinfection scenarios used in the preliminary
experiments. Bromide and iodide were added prior to the water entering the coagulation/settling process.
The same water source was used for both treatment scenarios; after coagulation/settling, the water
stream was split, and part entered the postchlorination treatment scenario and part entered the ozona-
tion/chlorination treatment scenario. Chlorine was added at the same point in the treatment process for
both the postchlorination disinfection scheme and the ozonation/chlorination disinfection scheme. (~6000 gallons per treatment scenario) that
needs to be concentrated for the proposed 
in vivo toxicology study outlined here (repro-
ductive, developmental, and cancer end
points) far exceeds the amount of water that
can be reasonably concentrated using XAD
resins. In addition, it is difﬁcult to redissolve
the organics into the water matrix required
for the in vivo study. XAD resins can be used
to concentrate DBPs in drinking waters for
mutagenicity testing because a water matrix is
not required. 
RO membranes have been used previously
to concentrate NOM (Gjessing et al. 1998;
Odegaard and Koottatep 1982; Serkiz and
Perdue 1990; Sun et al. 1995). Larger quanti-
ties of water can be concentrated more quickly
by RO membranes than by XAD techniques.
Membrane procedures will also keep the con-
centrated organics in a water matrix, unlike
the XAD technique where the compounds are
dissolved in organic solvents. For membrane
concentration, NOM and DBP recovery is a
function of the nature of the NOM or DBP,
membrane type, pH, temperature, and final
concentration. A molecule has a greater
chance of passing the membrane material if it
is small and uncharged. Volatile DBPs are
typically neutral, low-molecular-sized mole-
cules; therefore, they are expected to be lost to
various degrees during the membrane-concen-
tration procedure. Given the toxicological
importance of volatile DBPs (e.g., the THMs)
based on the decreased incidence of adverse
reproductive outcomes when chlorinated
water is heated or allowed to sit before con-
sumption (Waller et al. 1998), the concentrate
will need to be spiked, to the extent possible,
with the lost volatile DBPs. The feasibility of
returning to the concentrates those DBPs lost
during the concentration procedures is being
evaluated in the preliminary experiments. In
addition to DBP losses during concentration,
degradation and volatilization losses within
the holding basins for speciﬁc DBPs will have
to be tracked. This includes both organic and
inorganic DBPs and also applies to shipping
and animal cage–holding times. The develop-
ment of appropriate methodology for produc-
tion of water concentrates for in vivo animal
toxicological assessment is perhaps the most
difﬁcult challenge for implementation of the
full study. The preliminary studies are cen-
tered around evaluation of RO techniques and
assessment of the parameters for its use. As
outlined in the concept proposal (Simmons
JE. Personal communication), RO concentra-
tion would take place after disinfection. 
As mentioned above and confirmed in
preliminary experiments, concentration of
disinfected water by RO results in DBP
losses. Although known DBPs can be mea-
sured before and after RO concentration
and spiked back if they are lost during the
concentration process, this adds to the tech-
nical difficulty of the process. Additionally,
only known and measured chemicals can be
restored, and approximately 50% of TOX
comprises unknown chemicals. Realistically,
relatively few compounds can be spiked
back. Candidates include THMs and other
DBPs such as HAAs, HANs, and bromate,
i.e., those for which fast analytical turn-
around time may be expected and com-
pounds that can be purchased in sufficient
quantities. Spike-back is expected to be difﬁ-
cult; however, the importance of returning
such toxicologically significant compounds
as bromodichloromethane and chloroform
justiﬁes the effort of appropriate spike-back. 
Degree of Concentration by 
Reverse Osmosis
A 100-fold (100×) concentration factor was
selected as the initial target RO concentra-
tion. The rationale for this degree of concen-
tration is as follows: 
• Animals are not expected to drink severely
concentrated water because of taste aver-
sion. Decreased water consumption by
treated animals adds a confounding factor
(Simmons et al. 1994) that may be diffi-
cult to properly account for in the data. To
protect against confounding of experimen-
tal results by decreased water consump-
tion, palatability studies are included in
the preliminary experiments. 
• Mixtures studies should be conducted, to
the extent feasible, in the low-dose region of
health effects dose–response curves. 
• Water consumption demands are such that
concentration greater than 100× does not
appear feasible at this time. In addition, con-
centration to much greater than 100× is
likely to require XAD-resin methods, with
an expected increased loss of volatiles. XAD-
resin extraction procedures are generally not
compatible with generation of sufficient
extract for extended in vivo assessment.
• Concentration beyond 100× by RO would
be expected to lead to unacceptable
increases in various inorganic constituents,
which may cause fouling by precipitation/
scaling, result in elevated osmotic pressures,
or confound the results of the subsequent
health studies.
These considerations resulted in an initial
target of 100× concentration. Results from
the preliminary experiments will be examined
to assess the feasibility of using more highly
concentrated samples. 
Analytical Chemistry Analyses on
Water and Water Concentrates
Extensive analysis and quantitation of the
DBPs is a major goal of this work. Analyses
that will be run on the raw source water, the
in-plant waters, and 1x ﬁnished waters during
operation of the plants include measurements
of: temperature, pH, turbidity, particle counts,
ultraviolet absorbance at 254 nm, TOC,
biodegradable dissolved organic carbon
(DOC), hardness, alkalinity, coliform bacteria,
and bacterial endospores. Additionally, both
quantitative and qualitative chemical analyses
will be run variously on the raw water, the in-
plant waters, the 1× waters during operation of
the treatment plants, the 1× ﬁnished waters,
and the RO concentrates. The quantitative
analyses for those DBPs that tend to be rou-
tinely monitored are listed in Table 1. 
A number of DBPs not routinely quanti-
ﬁed will also be measured in the 1× ﬁnished
waters and in the RO concentrates. Gas chro-
matography–mass spectrometry (GC–MS)
analyses will be performed to provide qualita-
tive comprehensive chemical/DBP identiﬁca-
tion for all chemicals and DBPs detected.
This comprehensive chemical/DBP identifi-
cation effort will provide a more complete
picture of the DBPs present in the drinking
water. Similarly, GC–MS analyses conducted
during the preliminary experiments will aid
in evaluation of DBP stability during bulk
concentrate storage and placement on animal
cages. A comparison of chromatographic
peaks can be used to assess whether nontar-
geted chemicals in the unknown fraction are
being lost or concentrated, or if new chemi-
cals are formed. Although not quantitative, it
will give an approximate percentage loss dur-
ing this storage/rat cage time and will com-
plement the quantitative information
obtained for the targeted DBPs. The analytic
chemistry results from both the quantitative
and qualitative analyses will be used to deter-
mine the effectiveness of the concentration
procedures (what chemicals are lost and what
chemicals are preserved and to what extent)
and to evaluate chemical stability during con-
centrate storage and during animal-cage
placement. 
In addition to quantitation of the rou-
tinely measured DBPs and qualitative analysis
by GC–MS, we have proposed the inclusion
of quantitative analysis for more than 50
DBPs not routinely measured. These are the
more than 50 priority unregulated DBPs
(Table 2) recently quantiﬁed for a nationwide
DBP occurrence study (Weinberg et al.
2002). The DBPs were selected based on
structure-activity analysis according to proba-
ble adverse health effects. The health end
point for the selection exercise was cancer.
Also included are two chemicals, methyl bro-
mide and methyl-t-butyl ether, that are not
recognized as DBPs but are of concern in
drinking water. A few more chemicals were
added so ozone and chlorine dioxide DBPs
could be better represented. Addition of these
quantitative analyses will allow a more com-
plete characterization of the drinking water.
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Background Chemical
Contamination
The background chemical contamination of
the tested source water is an important issue, as
these chemicals will be concentrated along with
the DBPs. The EFL reservoir has a relatively
low background chemical load but is expected
to contain pesticides (mainly herbicides), as the
surrounding watershed is largely agricultural.
Existing data on background pesticide/herbi-
cide concentrations are being sought. Through
the U.S. Geological Survey (USGS) water qual-
ity monitoring program, pesticides have
been/are being monitored at EFL. Other back-
ground chemicals of concern include fuel
hydrocarbons such as benzene, toluene, and
xylenes, as the water intake area is close to a
public boat ramp. Previous measurements of
these hydrocarbon chemicals by NRMRL, U.S.
EPA, have indicated they are rarely present
(Miltner RJ. Personal communication).
In Vivo Toxicological Assessments
Planned for the Full Study
The Sprague-Dawley rat is the proposed
experimental subject. Although the Fischer-
344 (F-344) rat is more sensitive to chemi-
cally mediated pregnancy loss (Bielmeier 
et al. 2001; Narotsky et al. 2001), the choice
of Sprague-Dawley rats was based on several
factors: the high priority of the reproductive
and developmental end points; the reproduc-
tive toxicology guidelines specify that strains
with low fecundity (such as the F-344) shall
not be used; the database developed by
NHEERL on the male reproductive effects of
DBPs has been developed in the Sprague-
Dawley rat; and the Sprague-Dawley rat is
expected to produce sufficient pups to con-
duct the proposed full study as outlined
below. The route of exposure is oral; the
water concentrates will be provided to the rats
as their sole source of drinking water.
Based on the results of the more recent 
epidemiology studies (Bove et al. 1995;
Gallagher et al. 1998; Klotz and Pyrch 1999;
Kramer et al. 1992; Waller et al. 1998) and the
feasibility of conducting in vivo exposures, ﬁrst
priority was assigned to reproductive and
developmental end points, followed by cancer
end points. Cancer end points, although
important, were assigned a lower priority,
given the limited feasibility of obtaining
enough water concentrate to conduct an in
vivo 2-year cancer bioassay. Additional end
points are “piggy-backed” onto the reproduc-
tive and developmental end points where feasi-
ble. The piggy-backed experiments are an
important component of the overall study
design, as they greatly increase the spectrum
of target organs to be examined in the full
study. They include target organs known to
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Table 2. Chemical analyses for nonroutinely monitored DBPs. 
3,3-Dichloropropenoic acid (3,3-dichloroacrylic acid) 
Bromoacetonitrile [590-17-0]a
Chloroacetonitrile [107-14-2]
Tribromoacetonitrile [75519-19-6]
Bromodichloroacetonitrile [60523-73-1]
Dibromochloroacetonitrile [144772-39-4]
Chloropropanone (chloroacetone) [78-95-5]
1,3-Dichloropropanone (1,3-dichloroacetone) [534-07-6]
1,1- Dibromopropanone (1,1-dibromoacetone) 
1,1,3-Trichloropropanone (1,1,3-trichloroacetone) [921-03-9]
1-Bromo-1,1-dichloropropanone (1-bromo-1,1-dichloroacetone)
1,1,1,3-Tetrachloropropanone (1,1,1,3-tetrachloroacetone) [16995-35-0]
1,1,3,3-Tetrachloropropanone (1,1,3,3-tetrachloroacetone) [632-21-3]
1,1,3,3-Tetrabromopropanone (1,1,3,3-tetrabromoacetone)
1,1,1,3,3-Pentachloropropanone (pentachloroacetone)
Hexachloropropanone (hexachloroacetone) [116-16-5]
Dimethylglyoxal (2,3-butanedione)
Chloroacetaldehyde [107-20-0]
Dichloroacetaldehyde [70-02-7]
Bromochloroacetaldehyde
Tribromoacetaldehyde [115-17-3]
3-Chloro-4-(bromochloromethyl)-5-hydroxy-2(5H)-furanone (BMX-1)
3-Chloro-4-(dibromomethyl)-5-hydroxy-2(5H)-furanone (BMX-2)
3-Bromo-4-(dibromomethyl)-5-hydroxy-2(5H)-furanone (BMX-3)
(E)-2-Chloro-3-(bromochloromethyl)-4-oxobutenoic acid (BEMX-1)
(E)-2-Chloro-3-(dibromomethyl)-4-oxobutenoic acid (BEMX-2)
(E)-2-Bromo-3-(dibromomethyl)-4-oxobutenoic acid (BEMX-3)
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) 
3-Chloro-4-(dichloromethyl)-2-(5H)-furanone (red-MX)
(E)-2-Chloro-3-(dichloromethyl)-butendioic acid (ox-MX)
(E)-2-Chloro-3-(dichloromethyl)-4-oxobutenoic acid (EMX) 
2,3-Dichloro-4-oxobutenoic acid (mucochloric acid) [87-56-9]
Chloromethane (methyl chloride) [74-87-3]
Bromomethane (methyl bromide) [74-83-9]b
Dibromomethane [74-95-3]
Bromochloromethane [74-97-5]
Bromochloroiodomethane 
Dichloroiodomethane 
Dibromoiodomethane
Chlorodiiodomethane
Bromodiiodomethane
Iodoform [75-47-8]
Chlorotribromomethane 
Carbon tetrachloride [56-23-5]
1,1,1,2-Tetrabromo-2-chloroethane 
Bromochloromethyl acetate 
Chloroacetamide [79-07-2]
Bromoacetamide [683-57-8]
Dichloroacetamide [683-72-7] 
Dibromoacetamide
Trichloroacetamide [594-65-0]
Bromonitromethane [563-70-2]
Chloronitromethane
Dibromonitromethane
Bromochloronitromethane
Dichloronitromethane 
Bromodichloronitromethane
Dibromochloronitromethane
Tribromonitromethane (bromopicrin)
2-Hexenal [505-57-7]; [6728-26-3] 
5-Keto-1-hexanal 
Methylethyl ketone (2-butanone) [78-93-3] 
Cyanoformaldehyde 
6-Hydroxy-2-hexanone 
Methyl-tert-butyl ether [1634-04-4]b
Benzyl chloride
aChemical Abstracts Service (CAS) numbers listed when available. bNot a DBP but an important water contaminant.be affected by exposure to DBPs (liver, kid-
ney) and those where database limitations
preclude judgment regarding their potential
sensitivity to either single DBPs or DBP
mixtures (immunotoxicity, neurotoxicity,
developmental neurotoxicity). Given the
labor-intensive nature of production of the
water concentrates and the costs, both direct
and indirect, associated with production of
sufficient concentrate quantities to conduct
the proposed in vivo studies, it is important
to gain as much toxicological information as
possible from a single study. 
The full experiment is projected to consist
of a minimum of four treatment groups: a) a
control group that receives distilled deionized
water (analyzed to ensure there are no
remaining volatiles); b) a chlorination group
that receives the chlorinated water concen-
trate; c) an ozonation group that receives the
ozonated/chlorinated water concentrate; and
d) a positive control group testing a chemical
(either dibromoacetic acid or dichloroacetic
acid) known to be positive at the given dose
level for several priority end points. If feasible,
a concentrated raw-water control group will
be included that receives concentrated source
water (i.e., source water concentrated but not
chemically disinfected) to control for the
effects of the background contaminants pre-
sent in the source water. The feasibility of the
concentrated-source water control depends
on the availability of a procedure for estab-
lishing the microbial purity of the concen-
trated source water that does not also remove
the background contaminants of interest. The
number of rats per treatment group (see dis-
cussion below) will be inﬂuenced by both the
available volumes of water concentrates and
statistical power considerations.
The full study was designed based on the
assumption that the preliminary experiments
would indicate that the needed quantities of
water could be prepared and that the rats will
consume 100× water without toxicologically
significant self-imposed water restriction. If
decreased water consumption is noted in the
preliminary experiments, an additional
restricted-water control group may be
needed. The usefulness of a concurrent
restricted-water control group in understand-
ing the health effects associated with a com-
plex mixture of chemicals administered in the
drinking water has been demonstrated
(Simmons et al. 1994). In a study of this
nature, the appropriate control group must be
considered carefully. Although the untreated,
unconcentrated surface water (1×, raw water)
might appear to be a reasonable control, issues
of microbial and viral contamination might
prevent its use, and this control would not
control for background contamination as well
as the concentrated-source water control
mentioned above. Another possibility is to
use the disinfected, unconcentrated water
(1×, disinfected by chlorination, and 1×, dis-
infected by ozonation/chlorination) as con-
trols. In actuality, these represent very low
dose treatment groups rather than controls.
The size of the full study as presently planned
makes it difficult to include two additional
treatment groups without blocking the 
experimental design.
The full study can be logically broken
into three parts:
• Phase I: assays to be conducted between
GD0 and postnatal 21 (PND21).
• Phase II: assays to be conducted by carrying
the F1 offspring from PND21 to PND90,
with evaluation of the reproductive 
capabilities, female and male, of the F1
generation.
• Phase III: assays to be conducted by carry-
ing the F1 offspring from PND21 to
PND360.
The proposed full study, as presented in
the research concept proposal, is outlined in a
flow diagram (Figure 3), with each phase
detailed in a table (Table 3) that describes the
relationship of water exposure, GD, PND,
and toxicology assay. Table 3 also identifies
which tests and assays are conducted on the
same rat (dam or pup). 
In addition to the in vivo assays 
proposed in Table 3 and Figure 3, comple-
mentary in vitro assays are also proposed.
Included among these are reproductive/
developmental assays using embryo cultures or
cultures of isolated seminiferous tubules.
Research by Hunter et al. (1996) has shown
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PND21 PND25 PND35 PND50
Phase I
Exposure to water concentrates begins
GD0 GD21
20 F0 dams
pregnant
12 F0 dams
select dams with ≥ 8 pups
Terminate
(F0 dams)
PND1 PND6 PND11 PND21
F1 pups
Litter size = XX
F1 pups
8 ≤ litter size ≤ 12
6 female
6 male
F1 pups
8 ≤ litter size ≤ 10
5 female
5 male
Modified Chernoff/Kavlock
assay and anogenital
distance Use culled F1 pups
for neurotoxicity
assessment
Use culled F1 pups
for neurotoxicity
assessment
Terminate from each
 litter: 1 male and
 1 female
Tissue weights/
 testicular proteomics
Terminate from 6 litters: 1 male and 1 female
Reproductive and target organ toxicology
 (see Table 3)
F1 animals
No. litters = 6
Litter size = 8
4 female
4 male
F1 animals
No. litters = 6
Litter size = 6
3 female
3 male
Phase II
PND56 PND70 PND80 PND90
Puberty
assessment
female
begins
Puberty
assessment
male
begins
Estrous
cyclicity
female
begins
F1 No. litters = 6; 3 female, 2 male
F1 No. litters = 6; 2 male, 2 female
F1
No.
litters = 6
Size =
3 female
3 male
No.
litters = 6
Size =
4 female
4 male
Immunotoxicity
assessment
6 litters
Terminate
1 male
1 female
12 litters
1 male
F1 MATE
1 female
F1 Males
Pregnant
F1 female
Terminate
F1 female
Terminate 1 male;
assessment includes
artificial insemination
F2 pups
PND1: anogenital
distance; modified
Chernoff/Kavlock
assay
PND6: proteomics
skeletons
Assess crypt formation
at PND180, PND360
(see Table 3)
Terminate F1 animals;
see Table 3 for
assessments
6 Litters; 1 male
6 Litters;
2 female, 2 male Deionized drinking water to PND180, PND 360
Phase III, Exposure to water concentrates to PND 180
Figure 3. Flow diagram for the toxicology assays. The relationship between exposure to the water concen-
trate, GD, PND, and toxicology assay is illustrated. The movement of experimental animals between
Phases I, II, and III of the toxicology assays is shown. Chemical Mixtures • Integrated evaluation of complex mixtures of DBPs
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Table 3. The relationship between water exposure, GD, PND, and toxicology assay in the proposed toxicological evaluations.a,
GD or PND Toxicological evaluation or experimental activity
Phase I. Toxicological evaluation: exposure during pregnancy and lactation
Forty adult female Sprague-Dawley rats (60 days of age) arrive in facility—the F0 rats. These rats are monitored daily for estrus cycling.
Regularly cycling females are mated overnight with proven-fertile chemically naïve rats.
Twenty sperm-positive females are selected and begin receiving water concentrate on GD0.
GD0 Exposure to water concentrate begins.
GD1–GD21 Pregnant rats receive water concentrate throughout gestation; water and feed consumption are monitored; maternal weight gain, gestation
length, and pregnancy rate are measured.
PND1–PND21 Water and feed consumption of dams are monitored; dams are weighed periodically.
PND1 Twelve F0 dams with more than 8 pups are selected (ideally, selection will achieve 12 litters with at least 12 pups/litter); pups
are weighed, anogenital distance is measured; external defects are evaluated (noninvasive). Dams and litters not selected are 
terminated, with numeration of implantation sites in dams.
PND2 Ontogeny of the righting reﬂex (noninvasive)
PND3 Ontogeny of the righting reﬂex (noninvasive)
PND4 Ontogeny of the righting reﬂex (noninvasive)
PND6 Pups are weighed; external defects are evaluated; anogenital distance is measured (noninvasive).
PND6 Any of the 12 selected litters with more than 12 pups are culled to 12 (6 males and 6 females). Culled pups (1 male and 1 female
from each litter if available) are killed for assessment of alterations in regional markers of differentiation and apoptosis.
PND11 Any of the 12 litters with more than 10 pups are culled to 10 (5 males and 5 females). Culled pups (1 male and 1 female from
each litter if available) are killed for qualitative and quantitative neuropathology.
PND14 Male pups are assessed for retained nipples.
PND17 Functional observational battery and motor activity assessment are conducted. Those pups that will be terminated on PND21 are not 
assessed (noninvasive).
PND21 F0 dams are killed; implantation sites in dams are counted. In all 12 F1 litters, anogenital distance is measured. From all 12 F1 litters, 
one male and one female pup are terminated. From 6 litters, one additional male and one additional female pup are terminated. In 
both dams and pups, body and all major organ weights are measured; reproductive organ weights and histopathology in dams and pups 
are assessed; endocrine function is evaluated by measurement of TSH and T4 and by histopathological evaluation of the thyroid and 
the adrenal glands; testicular proteomics in male pups are evaluated. In both dams as well as male and female pups, blood and liver 
samples are taken for hepatotoxicity and nephrotoxicity evaluation; tissue samples are preserved for both indicator DBP analysis and 
for in vitro metabolism for assays; in pups, brains are assayed for alterations in regional markers of differentiation and apoptosis.
End of Phase I
Distribution of the remaining F1 pups is shown on the toxicology ﬂow diagram (Figure 3). At the end of Phase I there are 6 litters with 6 pups (3 male and 3 female) and 6 litters with
8 pups (4 male and 4 female). From the 6 litters with 8 pups each, 2 male and 2 female pups from each litter are placed on deionized drinking water; these rats are assayed for
colonic crypts at PND180 and PND360. From the 6 litters that have 6 pups each (3 male and 3 female), 1 male from each litter is placed in Phase III toxicological evaluation. These
rats are exposed to the water concentrate until PND180, when they are terminated and assayed for colonic crypts. All other pups are placed in Phase II toxicological evaluation.
Phase II. Toxicological evaluation; reproductive maturation of the F1 generation
PND21 The remaining pups at PND21 are divided into those going to Phase II toxicological evaluation and those going to Phase III toxicological
evaluation (see Phase III description, below). A total of 30 females and 24 males enter Phase II (see Figure 3, Phase II).
PND21 to termination All F1 animals receive water concentrate until termination. Water and feed consumption and body weight are monitored until termination.
PND25 Daily assessment for vaginal opening in F1 females begins.
PND35 Daily assessment for preputial separation in F1 males begins.
PND50–PND70 Daily monitoring of F1 females is conducted for estrus cycling.
PND63–PND85 One male and 1 female from each of 6 litters are evaluated for immunotoxicity. Rats are immunized with T-cell–dependent antigen
sheep erythrocytes on PND63 and PND80. On PND68, rats are monitored for primary (IgM) antibody titers and on PND86 for recall (IgG) 
antibody titers.
PND70–PND80 Daily mating (2–3 hr/day in light cycle between cycling F1 females and F1 males from separate litters); time to pregnancy and pregnancy
rate are measured.
PND90 F1 males and nonpregnant F1 females are terminated. All major organs, including reproductive organs, are weighed. Reproductive organ
histopathology is evaluated. Further assessments include the following: in females: enumeration of implantation sites; in males: 
enumeration of testicular and epididymal sperm numbers; testicular testosterone measurement, epididymal sperm motility and 
morphology, and ability to produce pregnancy through artiﬁcial insemination. Endocrine function is evaluated by measurement of TSH 
and T4 and by histopathological evaluation of the thyroid and the adrenal glands; testes are frozen for proteomics analysis; serum 
hormones (LH, testosterone, FSH, prolactin, inhibin) are measured; males and females are evaluated for aberrant colonic crypts.
Blood and liver samples are taken for hepatotoxicity and nephrotoxicity; tissue samples are taken for metabolism assays; tissue samples
are taken for indicator DBP analysis; brains are assayed for alterations in regional markers of differentiation and apoptosis; quantitative 
and quantitative neuropathology is assessed; immunotoxicity assessment includes proliferative potential of T and B lymphocytes and 
natural killer cell activity; blood is analyzed for serum levels of preformed immunoglobulins M, G, and A.
GD0–GD21, F1 dams Pregnant rats receive water concentrate throughout gestation; water and feed consumption are monitored; maternal weight gain, gestation
length, and pregnancy rate are measured.
PND1–PND6, F2 pups Water and feed consumption of dams are monitored; dams are weighed periodically.
PND1, F2 pups Pups are weighed, anogenital distance is measured; external defects are evaluated (noninvasive).
PND2, F2 pups Ontogeny of the righting reﬂex (noninvasive)
PND3, F2 pups Ontogeny of the righting reﬂex (noninvasive)
PND4, F2 pups Ontogeny of the righting reﬂex (noninvasive)
PND6, F2 pups F1 dams and F2 pups are killed. Assessments include the following: pups: weighed, external defects evaluated, anogenital distance 
measured, skeletal evaluation conducted; dams: weighed; implantation sites enumerated; reproductive organs evaluated; evaluation for
aberrant colonic crypts conducted. Blood and liver samples are taken for hepatotoxicity and nephrotoxicity; tissue samples are taken for
metabolism assays and indicator DBP analysis; brains are assayed for alterations in regional markers of differentiation and apoptosis; 
qualitative and quantitative neuropathology is assessed.
End of Phase II
(continued)HAAs are toxic to the developing embryo.
Isolated seminiferous cultures were selected
to evaluate effects on spermatogenesis.
Mutagenicity assays include both the standard
Salmonella assay with and without metabolic
activation, and the Salmonella assay with glu-
tathione S-transferase (GST)–transfected bac-
teria. Inclusion of in vitro mutagenicity assays
with the standard Salmonella strains is based
on the literature database demonstrating that
water samples concentrated by extraction
methods that result in the loss of volatile
organic matter are mutagenic (Simmons et al.
2001). Inclusion of assays that employ a
Salmonella strain transfected with rat theta-
class GST T1-1 is based on the demonstrated
mutagenicity of DBPs in this assay system.
Brominated THMs are potent mutagens in
this assay but not the standard Salmonella
assay, indicating the important role of meta-
bolic activation through conjugation with glu-
tathione in brominated THM-mediated
genotoxicity (Pegram et al. 1997). In vitro
assays for carcinogenicity and neurotoxicity
have also been proposed. Additionally, blood
and tissue samples will be prepared and stored
(quick-frozen in liquid nitrogen and stored at
–80°C) for possible future analyses. This is
important, given the degree of difﬁculty and
effort involved in the preparation of the con-
centrated water samples for subchronic in vivo
toxicological assessment. 
Meaning of Positive Result(s) and
Possible Future Directions
A positive result for any end point demon-
strates toxicity that can be attributed to the
chemicals present in the water concentrate.
Although this project is meant to assess
health effects due to DBPs, it must be
remembered that any background chemical
contamination of the source water must also
be considered, as the concentration proce-
dures used to concentrate the DBPs will also
concentrate background contaminants of the
source water.
With positive results from both water
treatment scenarios, or positive results from
one water treatment scenario and negative
results from the other treatment scenario,
the comparative toxic potency of the two
water treatment scenarios can be evaluated.
This will provide useful information with
regard to shifts or alterations in toxic out-
come that might be expected with shifts in
water treatment scenario.
The analytical chemistry information will
be used to develop predictive models. The
results of the predictive models will be com-
pared with the observed toxicological out-
comes (positive or negative). The expected
toxic potency of the mixtures under an
assumption of additivity (both dose and
response) will be calculated. These predicted
toxicity estimates will make use of statistical
procedures and risk assessment techniques
such as the Gennings additivity model
(Gennings et al. 1997).
Possible future directions resulting from a
positive toxicology outcome include
• Use of the chemical characterizations to
develop mechanistic hypotheses with
respect to chemicals or subsets of chemicals
expected to be responsible for the observed
toxic effects. These hypotheses may be
tested experimentally in follow-up studies. 
• Dose–response assessments (tests at 50, 25,
and 1×) to determine the shape of the
dose–response curve as the total mixture
decreases. However, the number of rats and
the related water concentrate volumes
required for dose–response assessment will
prove technically challenging.
•A  positive toxicological result from either
disinfection scheme may lead to research to
identify those factors that reduce the forma-
tion of toxic chemicals. Factors for consider-
ation, besides the bromide and iodide levels,
include pH, ozone dose, chlorine dose, and
temperature, among others. A positive result
in the mutagenicity assays conducted with
Salmonella, particularly Salmonella trans-
fected with GST-theta, may lead to bioassay-
directed fractionation. This type of research
can pinpoint the mutagenic fractions and aid
in identiﬁcation of those chemicals responsi-
ble for the mutagenic response.
Meaning of Negative Result(s) 
and Next Steps
If all the toxicological assays are negative, then
no toxicity was observed that could be attrib-
uted to exposure to these complex mixtures of
DBPs. The toxicology assays are weighted
toward reproductive and developmental end
points and include exposure during gestation of
the F1 generation to production of F2 pups.
The inclusion of the positive control chemical
adds weight to the assumption that if reproduc-
tive or developmental effects were observable in
animals, we would have detected them with
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Table 3. (Continued)
GD or PND Toxicological evaluation or experimental activity
Phase III. Development of aberrant colonic crypts
PND21 A total of 30 rats enter Phase III. Only 6 male rats (from separate litters) will continue to receive water concentrate. These 6 rats will 
receive water concentrate until termination. The other 24 rats (12 males and 12 females) will receive deionized water, beginning
at PND21.
These rats will receive deionized water until termination (see Figure 3, Phase III).
Various times between Functional observational battery and motor activity assessment are conducted. Periodic testing is conducted between PND21 and PND180,
PND21 and PND180 with the timing and frequency of these assessments based on the results of the PND17 testing in Phase I (noninvasive).
PND158–PND180 The 6 male rats that continue to receive water concentrate are evaluated for immunotoxicity. Rats are immunized with T-cell–dependent 
antigen sheep erythrocytes and monitored for primary (IgM) antibody titers and for recall (IgG) antibody titers.
PND180 The 6 rats that continued to receive water concentrate are terminated. Six males and 6 females that received deionized water beginning
on PND21 are terminated. Both sets of rats are evaluated for presence of aberrant crypts; major organs are evaluated for tumors; 
endocrine function is evaluated by TSH and T4 and by histopathological evaluation of the thyroid and the adrenal glands. Blood and 
liver samples are taken for hepatotoxicity and nephrotoxicity; tissue samples are taken for metabolism assays; tissue samples are 
taken for indicator DBP analysis (water concentrate rats only); brains are assayed for alterations in regional markers of differen- 
tiation and apoptosis; qualitative and quantitative neuropathology is assessed. Immunotoxicity assessment includes proliferative 
potential of T and B lymphocytes and natural killer cell activity; blood is analyzed for serum levels of preformed immunoglobulins
M, G, and A.
PND360 The remaining 6 males and 6 females that received deionized water beginning on PND21 are terminated. Rats are evaluated for 
presence of aberrant colonic crypts; major organs are evaluated for tumors; endocrine function is evaluated by measurement of TSH 
and T4 and by histopathological evaluation of the thyroid and the adrenal glands. Blood and liver samples are taken to assess 
hepatotoxicity and nephrotoxicity; tissue samples are taken for metabolism assays; brains are assayed for alterations in regional
markers of differentiation and apoptosis; qualitative and quantitative neuropathology is assessed. Immunotoxicity assessment includes
proliferative potential of T and B lymphocytes and natural killer cell activity; blood is analyzed for serum levels of preformed 
immunoglobulins M, G, and A.
End of Phase III
Abbreviations: FSH, follicle-stimulating hormone; LS, luteinizing hormone; T4, tetraiodothyronine; TSH, thyroid-stimulating hormone. aThis table illustrates one exposure group. The full
experiment, as planned, has four exposure groups (distilled deionized water control group, chlorination concentrate, ozonation/chlorination concentrate, positive control).our study design. (This statement has the most
validity under an assumption of common
mode of action.) Statistical power calculations
(see below) are being conducted in advance of
the full study. Given that the full study has suf-
ﬁcient statistical power, a lack of concordance
of animal results and the epidemiologic studies
might suggest a research focus on the chemicals
suspected of being background contaminants
in the waters examined by epidemiologic inves-
tigation. Alternatively, hypotheses that could be
developed include the following: that the epi-
demiologic end points do not have a chemical
basis; that the experimental animal used is less
sensitive than humans to the adverse health
effects associated with exposure to complex
mixtures of DBPs; or that higher dose levels are
required to elicit adverse health effects when
exposure is limited to the oral route. The other
health end points (e.g., immunotoxicology) are
less fully examined in the proposed experimen-
tal design, so it is possible further testing would
reveal a positive effect. Cancer is a particular
concern, as technical limitations prohibit the
conduct of a traditional 2-year bioassay. With
regard to the issue of susceptible subpopula-
tions, this research addresses the susceptibility
of the developing embryo and the young ani-
mal. Questions regarding potential enhance-
ment of susceptibility due to nutrition, disease,
or advanced age are not considered here. 
The preliminary results will be used to
calculate a sample size for the full study that
allows for a reasonable Type II error rate
(beta), i.e., the probability of not detecting an
effect when one is truly present. The sample
size currently suggested, 20 sperm-positive
females culled to 12 dams with litter size
greater than 8 on PND1, is based on stan-
dard guidelines for reproductive/developmen-
tal studies. Note that a small Type I error rate
(alpha) is also required; Type I error is the
probability of a false positive result, i.e.,
detecting an effect when one is really not
there. As it is desirable for alpha to be low, it
is usually set at p < 0.05. Generally, alpha is
set at a nominal level, and beta is calculated
for the statistical test(s) of interest, using esti-
mates of sample size and variance of the toxic
end point to be measured. Both alpha and
beta can be reduced with larger sample sizes
and by selecting end points that can be tested
using a one-tailed statistical test. Because the
concentration methods discussed herein will
necessarily limit the amount of water avail-
able to dose the animals and thus limit the
number of animals in the study, sample sizes
will necessarily be small. Power calculations
then become important as a method for
choosing among the possible toxic end points
for the full study. For example, if sample size
is limited by the amount of water to n = 10,
and alpha is required to be < 0.05, then beta
is affected by the choice of toxic end point,
including the sensitivity of that end point and
our ability to correctly estimate the expected
value and variance of that end point. Thus,
the projected power of the statistical test to
detect an effect will be critical to the design of
the full study and will rely on data from the
trial run and from previous toxicity studies. 
Potential Risk Assessment Uses 
of the Data
The data developed through the conduct of
this project are important for risk assessment in
three ways: a) as toxicity data for estimating
DBP risks from exposure to the complex mix-
ture that can be used to compare health risks
across treatment trains and to contrast with
risk estimates using epidemiologic data; b) as
complex mixture data that can be used in con-
junction with existing data on single DBPs and
deﬁned mixtures to evaluate the toxicity of the
unidentiﬁed fraction of the DBPs produced;
and c) as exposure and toxicity data that can be
used to aid in the development and reﬁnement
of emerging mixture risk assessment method-
ologies (e.g., for evaluation of the accuracy of
component-based approaches to estimating
DBP risks; as exposure data on a variable com-
plex mixture over time).
Estimation of complex mixtures health
risks. The problem of characterizing health
risks from exposure to DBPs across different
drinking water treatment trains is being
investigated. The most recent effort uses a
component-based approach, response addi-
tion, to estimate these risks (U.S. EPA
2000a). Response addition assumes each
component of the mixture acts toxicologically
in a functionally independent way for a given
effect; thus, at low exposure levels, the risks of
the individual chemicals can be added
together to estimate the risk of the adverse
effect for the whole mixture (U.S. EPA
2000b). To include potential toxicity from
exposure to the unidentified fraction in the
risk assessment, the chemicals most likely to
be present in the fraction were identified. A
quantitative structure–activity relationship
(QSAR) model (Moudgal et al. 2000) was
then used to estimate the toxicity of those
chemicals. This information was used to esti-
mate risk from exposure to the unidentified
fraction, which was added to the estimated
risk from the known chemicals to produce a
whole-mixture risk estimate. This approach,
although a reasonable and defensible method,
may not accurately estimate the real health
risks. The data from the proposed full study
will be useful in testing the response addition
assumption and QSAR approach, along with
other assumptions and methods, to find the
best technique for DBP mixtures health risk
estimation. An additional goal is to compare
health risk estimates based on animal toxicol-
ogy data with those from the epidemiologic
literature. Hypotheses can then be tested
regarding why differences exist between esti-
mates from the two data sources (e.g., 
contributions to toxicity by non-DBP conta-
minants in the water or from inhalation and
dermal exposures to DBPs), leading to further
research efforts.
Toxicity of the unidentified fraction.
Another potential use of these data is to
develop a method to attribute a certain pro-
portion of the toxicity to known chemicals,
and thus attribute the rest of the toxicity to
the unidentified portions of the DBPs pro-
duced. The risk from exposure to the known
chemicals may be estimated in several ways,
including the response-addition method
shown above. Other methods, such as dose-
addition approaches (e.g., relative potency
factors) or multiple-chemical dose–response
models, may also be employed. An example
of the latter, Gennings et al. (1997), uses data
on the four THMs to demonstrate a model-
ing approach that detects departures from
additivity for the mixture. The same model
may be useful in predicting the toxicity from
exposure to the known chemicals, including
the THMs, which could then be contrasted
with the toxicity observed from exposure to
the whole mixture. The model is based on
one definition of additivity given by
Berenbaum (1985), that is, in a combination
of c chemicals, let di represent the concentra-
tion/dose of the ith component alone that
yields a fixed response and let Dxi represent
the concentration/dose of the ith component
in combination with the c agents that yields
the same response. According to this defini-
tion, if the substances combine under dose
addition (with no interaction effects), then 
d1/Dx1 + d2/Dx2 + di/Dxi = 1.
The experimental data necessary and 
sufficient to support the estimation of this
additivity surface are single-chemical
dose–response data. The additivity surface
(estimated using the single-chemical data) can
be used to predict the response under additiv-
ity at the mixture point of interest. For
deﬁned mixtures (i.e., all components of the
mixture are known) with monotonically
increasing dose–response curves, the response
is considered synergistic when the observed
response is greater than the predicted response
under additivity; the response is considered
antagonistic when the observed response is less
than the predicted response under additivity.
When the mixture contains unidentified
chemicals and an assumption of dose addition
for the known chemicals in the mixture is
deemed reasonable, the observed experimental
response from exposure to the complex mix-
ture could be compared with the response pre-
dicted by this model, and the difference used
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fraction. The development of such a statistical
estimation process that contends with uniden-
tiﬁed fractions of complex mixtures may have
application beyond the study of DBPs.
Present Status
Substantial progress has been made to date.
The research concept proposal was completed
and has undergone external peer review. In
addition to a number of smaller preliminary
experiments, a large trial-run experiment has
been completed that involved the laboratories
of 15 scientists (L. Claxton, NHEERL;
A. DeAngelo, NHEERL; S. Hunter,
NHEERL; S. Krasner, MWDSC; G.
Klinefelter, NHEERL; R. Miltner, NRMRL;
M. Narotsky, NHEERL; R. Pegram,
NHEERL; G. Rice, NCEA; S. Richardson,
NERL; K. Schenck, NRMRL; J. E. Simmons,
NHEERL; T. Speth, NRMRL; L. Teuschler,
NCEA; H. Weinberg, UNC-Chapel Hill) in
five locations around the United States
(Cincinnati, Ohio; Athens, Georgia; La Verne,
California; Chapel Hill, North Carolina; and
Research Triangle Park, North Carolina). We
are currently in the ﬁnal stages of analyzing the
data resulting from this trial run experiment.
Results from the trial run led us to design and
conduct a follow-up experiment to assess the
potential for artifact formation during the
water concentration procedures used in the
trial run. Results from the artifact formation
experiment will aid our interpretation of the
trial run results. 
In conclusion, we have designed a research
strategy for integrated technology-based toxi-
cological and chemical evaluation of the highly
complex mixtures of chemicals formed during
chemical disinfection of water. Experiments
necessary to the ability to conduct the full
study, as proposed here, have been conducted
and their results are being used to inform and
guide the next steps in the process. 
REFERENCES
AWWA Water Quality Division Disinfection Systems Committee.
2000. J Am Water Works Assoc 92:32–43 (2000).
Berenbaum MC. 1985. The expected effect of a combination of
agents: the general solution. J Theor Biology 114:413–431.
Bielmeier SR, Best DS, Guidici DL, Narotsky MG. 2001.
Pregnancy loss in the rat caused by bromodichloro-
methane. Toxicol Sci 59:309–315.
Bull RJ, Robinson M, Meier JR, Stober J. 1982. Use of biologi-
cal assays to assess the relative carcinogenic hazards of
disinfection by-products. Environ Health Perspect
46:215–227.
Bove FJ, Fulcomer MC, Klotz JB, Esmarat J, Dufﬁcy EM, Savrin
JE. 1995. Public water contamination and birth outcome.
Am J Epidemiol 141:850–862.
Cantor KP. 1997. Drinking water and cancer. Cancer Causes
Control, 8:292–308.
Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J,
Alavanja M, et al. 1998. Drinking water source and chlori-
nation byproducts. Risk of bladder cancer. Epidemiology
9:21–28.
Fair PS. 1995. Inﬂuence of water quality on formation of chlori-
nation byproducts. In: Drinking Water: Critical Issues in
Health Effects Research: Workshop Report. Washington:
ILSI Press, 14–17.
Federal Register. 1994. National Primary Drinking Water
Regulations: Disinfectant and Disinfection Byproducts:
Proposed Rule. Fed Reg 59:38668.
Freedman DM, Cantor KP, Lee NL, Chen LS, Lei HH, Ruhl CE, 
et al. 1997. Bladder cancer and drinking water: a popula-
tion based study in Washington County, Maryland. Cancer
Causes Control 8:738–744.
Gallagher MD, Nuckols JR, Stallones L, Savitz DA. 1998.
Exposure to trihalomethanes and adverse pregnancy out-
comes. Epidemiology 9:484–489.
Gennings C, Schwartz P, Carter WH Jr, Simmons JE. 1997.
Detection of departures from additivity in mixtures of
many chemicals with a threshold model. J Agric Biol
Environ Stat 2:198–211. Erratum. 5:257–259 2000.
Gjessing ET, Alberts JJ, Bruchet A, Egeberg PK, Lydersen E,
McGown LB, et al. 1998. Multi-method characterization of
natural organic matter isolated from water: characteriza-
tion of reverse osmosis-isolates from water of two semi-
identical dystrophic lakes basins in Norway. Water Res
32:3108–3124.
Gonzalez AC, Krasner SW, Weinberg H, Richardson SD. 2001.
Determination of newly identiﬁed disinfection byproducts
in drinking water. The American Water Works Association
Water Quality Technology Conference, 6–10 November
2001, Nashville, Tennessee. Denver, CO:American Water
Works Association, 2001.
Hunter ES III, Rogers EH, Schmid JE, Richard A. 1996.
Comparative effects of haloacetic acids in whole embryo
culture. Teratology 4:57–64.
Kavlock R, Chernoff N, Carver B. 1979. Teratology studies in
mice exposed to drinking water concentrates during
organogenesis. Food Cosmet Toxicol 17:343–347.
King WD, Marrett LD. 1996. Case-control study of bladder can-
cer and chlorination by-products in treated water. Cancer
Causes Control 7:596–604.
Khiari DS, Ventura R, Barrett SE. 1999. Occurrence of iodo-tri-
halomethanes in drinking water. 217th American Chemical
Society National Meeting, 21-25 March 1999, Anaheim,
CA. Washington, DC:American Chemical Society, 1999.
Klotz JB, Pyrch LA. 1999. Neural tube defects and drinking
water disinfection by-products. Epidemiology 10:383–390.
Kramer MD, Lynch CF, Isacson P, Hanson JW. 1992. The asso-
ciation of waterborne chloroform with intrauterine growth
retardation. Epidemiology 5:407–413.
Krasner SW. 2001. Chemistry and occurrence of disinfection
by-products. In: Microbial Pathogen and Disinfection By-
Products in Drinking Water: Health Effects and
Management of Risks (Craun, GF, Hauchman FS, Robinson
DE, eds). Washington, DC:ILSI Press, 197–210. 
Loper JC, Lang DR, Schoeny RS, Richmond BB, Gallagher PM,
Smith CC. 1978. Residue organic mixtures from drinking
water show in vitro mutagenic and transforming activity. J
Toxicol Environ Health 4:919–938.
McGeehin MA, Reif JS, Becher JC, Mangione E. 1993. Case-
control study of bladder cancer and water disinfection
methods in Colorado. Am J Epidemiol 138:492–501.
Miltner RJ, Summer RS, Dugan NR, Koechling M, Moll DM.
1996. A comparative evaluation of biological filters. In:
Proceedings of the AWWA Water Quality Technology
Conference, 17–21 November 1996, Denver, Colorado.
Denver, CO:American Water Works Association, 1996.
Moudgal CJ, Lipscomb JC, Bruce RM. 2000. Potential health
effects of drinking water disinfection byproducts using
quantitative structure toxicity relationships. Toxicology
147:109–131.
Narotsky MG, Best DS, Guidici DL, Cooper RL. 2001. Strain
comparisons of atrazine-induced pregnancy loss in the
rat. Reprod Toxicol 15:61–69.
Odegaard H, Koottatep S. 1982. Removal of humic substances
from natural waters by reverse osmosis. Water Res
16:613–620.
Onstad GD, Weinberg HS, Krasner SW, Richardson SD. 2001.
Evolution of analytical methods for halogenated furanones
in drinking water. The American Water Works Association
Water Quality Technology Conference, 6–10 November
2001, Nashville, Tennessee. Denver, CO:American Water
Works Association.
Owens JH, Miltner RJ, Rice EW, Johnson CH, Dahling DR,
Schaeffer FW, et al. 2001. Pilot-scale ozone inactivation of
Cryptosporidium and other microorganisms in natural
water. Ozone Sci Eng 22:501–517. 
Pegram RA, Andersen ME, Warren SH, Ross TM, Claxton LD.
1997. Glutathione S-transferase-mediated mutagenicity of
trihalomethanes in Salmonella typhimurium: contrasting
results with bromodichloromethane and chloroform.
Toxicol Appl Pharmacol 144:183–188.
Regli S, Berger P, Macler B, Hass C. 1993. Proposed decision
tree analysis for management of risks in drinking water:
consideration for health and socioeconomic factors. In:
Safety of Water Disinfection: Balancing Chemical and
Microbial Risks (Craun GF, ed). Washington, DC:ILSI
Press, 39–80.
Richardson SD. 1998. Drinking water disinfection byproducts.
In: The Encyclopedia of Environmental Analysis and
Remediation (Meyers RA, ed). New York:John Wiley and
Sons, 1398–1421. 
Richardson SD, Simmons JE, Rice G. 2002. Disinfection byprod-
ucts: the next generation. Environ Sci Technol
36:197A–205A.
Serkiz SM, Perdue EM. 1990. Isolation of dissolved organic
matter from Suwannee River using reverse osmosis.
Water Res 24:911–916.
Simmons JE, Teuschler LK, Gennings C. 2001. The toxicology of
disinfection by-product mixtures: methods for multi-chem-
ical assessment; present research efforts; and, future
research directions. In: Microbial Pathogen and
Disinfection By-Products in Drinking Water: Health Effects
and Management of Risks (Craun GF, Hauchman FS,
Robinson DE, eds). Washington, DC:ILSI Press, 325–340. 
Simmons JE, Yang RSH, Svendsgaard DJ, Thompson MB,
Seely JC, McDonald A. 1994. Toxicology studies of a
chemical mixture of 25 groundwater contaminants:
hepatic and renal assessment, response to carbon tetra-
chloride challenge, and influence of treatment-induced
water restriction. J Toxicol Environ Health 43:305–325.
Singer PC. 1995. Disinfection by-products: from source to tap. In:
Drinking Water: Critical Issues in Health Effects Research:
Workshop Report. Washington, DC:ILSI Press, 7–8. 
Stevens AA, Moore LA, Slocum CJ, Smith BL, Seeger DR,
Ireland JC. 1990. In: Water Chlorination: Chemistry,
Environmental Impact and Health Effects, Vol. 6 (Jolley RL,
Condie LW, Johnson JD, Katz S, Minear RA, Mattice JS,
Jacobs VA, eds). Chelsea, MI:Lewis Publishers, 579–604.
Summers RS, Hooper SM, Shukairy HM, Solarik G, Owen D.
1996. Assessing DBP yield: uniform formation conditions.
J Am Water Works Assoc 88:80–93.
Sun L, Perdue EM, McCarthy JF. 1995. Using reverse osmosis
to obtain organic matter from surface and ground waters.
Water Res 29:1471–1477.
U.S. EPA. 2000a. Conducting a Risk Assessment of Mixtures of
Disinfection By-Products (DBPs) for Drinking Water
Treatment Systems. NCEA-C-0791. Cincinnati, OH:U.S.
Environmental Protection Agency.
U.S. EPA. 2000b. Supplementary Guidance for Conducting
Health Risk Assessment of Chemical Mixtures. EPA/630/R-
00/002. Washington, DC:U.S. Environmental Protection
Agency.
Waller K, Swan SH, DeLorenze G, Hopkins B. 1998.
Trihalomethanes in drinking water and spontaneous abor-
tion. Epidemiology 9:134–140.
Weinberg HS, Krasner SW, Richardson SD 2001. Determination
of new carbonyl-containing disinfection byproducts in
drinking water. The American Water Works Association
Water Quality Technology Conference, 6–10 November,
2001, Denver, Colorado. Denver, CO:American Water
Works Association, 2001.
Weinberg HS, Krasner SW, Richardson SD, Thruston AD Jr.
2002. The Occurrence of Disinfection By-Products (DBPs)
of Health Concern in Drinking Water: Results of a
Nationwide DBP Occurrence Study. EPA/600/R-02/068.
Athens, GA:U.S. Environmental Protection Agency.
Wilcox P, van Hoof F, van der Gaag M. 1986. Isolation and
characterization of mutagens from drinking water. In:
Proceedings of the XVIth Annual Meeting of the European
Environmental Mutagen Society (Leonard A, Kirsch-
Volders M, eds). Brussels, Belgium, 92–103.
Chemical Mixtures • Simmons et al.
1024 VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 • Environmental Health Perspectives